Monogram Technologies Inc. (MGRM)
6.00
0.00 (0.00%)
Inactive · Last trade price on Oct 6, 2025
Company Description
Monogram Technologies Inc. engages in developing surgical robot to enable placement of patient optimized orthopedic implants in the United States.
It intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.
The company was formerly known as Monogram Orthopaedics, Inc. and changed its name to Monogram Technologies Inc. in May 2024.
Monogram Technologies Inc. was founded in 2015 and is headquartered in Austin, Texas.
Monogram Technologies Inc.
| Country | United States |
| Founded | 2016 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 27 |
| CEO | Benjamin Sexson |
Contact Details
Address: 3913 Todd Lane, Suite 307 Austin, Texas 78744 United States | |
| Phone | 512 399 2656 |
| Website | monogramtechnologies.com |
Stock Details
| Ticker Symbol | MGRM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001769759 |
| CUSIP Number | 609786108 |
| ISIN Number | US6097861081 |
| Employer ID | 81-2349540 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Benjamin Sexson C.F.A. | Chairman of the Board, President and Chief Executive Officer |
| Dr. Douglas Unis | Founder, Chief Medical Officer and Director |
| Noel Knape CPA, M.B.A. | Chief Financial Officer |
| Dr. Kamran Shamaei Ph.D. | Chief Technology Officer |
| Chris Tyson | Executive Vice President - MZ North America |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 7, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Oct 7, 2025 | POS AM | Post-Effective amendments for registration statement |
| Oct 7, 2025 | POS AM | Post-Effective amendments for registration statement |
| Oct 7, 2025 | 8-K | Current Report |
| Oct 7, 2025 | 25-NSE | Filing |
| Sep 30, 2025 | 8-K | Current Report |
| Sep 12, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Sep 5, 2025 | 425 | Filing |
| Sep 5, 2025 | 8-K | Current Report |
| Aug 29, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |